Xenon Pharmaceuticals Inc.

James Roy Empfield

Christoph Martin Dehnhardt

Sultan Chowdhury

Alla Yurevna Zenova

Thilo Focken

Michael Edward Grimwood

Robert Joseph Devita

Jean-Christophe Andrez

Kristen Nicole Burford

Syed Abid Hasan

James Philip Johnson, Jr

Charles Jay Cohen

David Earl Bogucki

Qi Jia

Michael Scott Wilson

Shannon Marie Decker

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

Benzenesulfonamide compounds and their use as therapeutic agents

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.

Benzenesulfonamide compouds and their use as therapeutic agents

This invention is directed to methods of preparing benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

Growing community of inventors

Natick, MA, United States of America

James Roy Empfield